Clinical Trial Update: Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating short-course radiotherapy with tumor-draining lymph node preservation followed by a PD-1 inhibitor in patients with stage II-I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Rectal Cancer, Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING